Evaluation of efficacy of BIORAD D10TM testing system in detection of beta thalassaemia carrier

Debajyoti Singha Roy, Riju Bhattacharyya, Kaushik Mukhopadhyay, Debasis Bandopadhyay


Background: Hemoglobinopathies especially thalassaemia and its interaction with HbE and HbS are significant cause of morbidity and mortality in our country. With no feasible treatment, prevention of cases by carrier detection is the only option for successful reduction of the disease burden. VARIANT hemoglobin testing system BIORAD using principle of cation exchange chromatography has been in use and considered as gold standard for carrier detection. The purpose of this study is to compare the efficacy of a different, cheaper instrument; D10 by the same manufacturer BIORAD for carrier detection in beta thalassaemia.

Methods: Patients diagnosed as beta thalassaemia carrier by VARIANT hemoglobin testing system (HbA2 value between 4.0-9.0) were retested using D10 instrument and checked for agreement.

Results: There was good correlation between VARIANT and D-10 methods with Intraclass correlation coefficient 0.832 (95% Confidence Interval 0.756-0.884). Bland-Altman analysis showed mean bias of +0.3526 (95% CI -0.3958 to +1.101).

Conclusions: Although further study is needed with larger sample size for assessment of sensitivity and specificity of D10 instrument, it is evident from this study that this instrument can be an effective and cheaper alternative of VARIANT hemoglobin testing system.


Beta thalassaemia, BIORAD D10, BIORAD variant, Carrier, Detection

Full Text:



Madan N, Sharma S, Sood SK, Colah R, Bhatia HM. Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. Ind J Hum Genet. 2010;16(1):16-25.

Balgir RS. Genetic epidemiology of the three abnormal hemoglobins in India. J Assoc Physicians Ind. 1996;44:25-8.

Wild BJ, Bain BJ. Investigation of abnormal hemoglobins and thalassemia. In Lewis SM, Bain BJ, Bates I, eds. Dacie and Lewis Practical Hematology. 9th ed. Churchill Livingstone; 2001:231-268.

Wilson JB, Headlee ME, Huisman TH: A new high-performance liquid chromatographic procedure for the separation and quantitation of various haemoglobin variants in adults and newborn babies. J Lab Clin Med. 1983;102:174-86.

Bland JM, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-10.

Thomas ED, Sanders JE, Buckner CD, Papayannopoulou T, Borgna-Pignatti C, De Stefano P, et al. Marrow transplantation for thalassaemia. The Lancet. 1982 Jul 31;320(8292):227-9.

Galanello R, Barella S, Gasperini D, Perseu L, Paglietti E, Sollaino C, et al. Evaluation of an automatic HPLC analyser for thalassemia and haemoglobin variants screening. J Analytical Meth Chem. 1995;17(2):73-6.

Gwendolyn M, Higgins C, Higgins T. Laboratory investigation of hemoglobinopathies and thalassemias: review and update. Clin Chem. 2000;46:1284-90.

Ou CN, Rognerud CL. Diagnosis of hemoglobinopathies: electrophoresis vs. HPLC. Clin Chim Acta. 2001;313:187-94.

Riou J, Godart C, Didier H, Mathis M, Bimet C, Bardakdjian-Michau J, et al. Cation-exchange HPLC evaluated for presumptive identification of hemoglobin variants. Clin Chem. 1997;43:34-9.

VARIANT Hemoglobin Testing System [BIO- RAD] [pamphlet]. California: Bio-Rad Laboratories, Hercules; USA; 2011.

D-10TM Hemoglobin Testing System [BIO-RAD] [pamphlet]. California: Bio-Rad Laboratories, Hercules; 2010.